Comparison of cell attachment and caseinolytic activities of five tumour cell types.
We have examined the ability of 5 tumour cell types to attach to plastic flasks in medium containing either 10% foetal calf serum or 10% normal human serum and compared this ability with cell-associated caseinolytic activity. The cell types used included fibrosarcoma cells which were obtained from a methylcholanthrene-induced tumour in a C57 BL/6 mouse, the SV40-transformed 3T3 (BALB/c) cells, the Walker carcinosarcoma cells and 2 lines of HeLa cells. All 5 cell types attached to the flasks and spread out efficiently in medium containing 10% foetal calf serum. The walker carcinosarcoma cells and the 2 lines of HeLa cells also attached efficiently in medium containing 10% normal human serum and grew into monolayers in this medium. These 3 cell types had no detectable caseinolytic activity. The fibrosarcoma cells and the SV40-transformed 3T3 (BALB/c) cells did not attach in normal human serum-containing medium. These 2 cell types had readily detected caseinolytic activity. Normal human serum and foetal calf serum were compared for levels of protease-inhibitor activity. Human serum was found to have less activity than foetal calf serum against both trypsin and plasmin as well as the cell-associated caseinolytic activity. The low level of protease inhibitor activity in normal human serum may contribute to the inability of this serum to support the attachment of cells with detectable protease activity because the addition of protease inhibitors such as soybean trypsin inhibitor, lima bean trypsin inhibitor and bovine pancreas trypsin inhibitor to normal human serum dramatically enhanced cell attachment. In contrast to this, the addition of E-amino-n-caproic acid to normal human serum and the removal of plasminogen from normal human serum did not enhance its capacity to support cell attachment.
D000818:Animals; D002364:Caseins / Q000378:metabolism*; D002448:Cell Adhesion; D002478:Cells, Cultured; D003470:Culture Media; D006367:HeLa Cells / Q000378:metabolism; D006358:Hot Temperature; D006801:Humans; D051379:Mice; D009374:Neoplasms, Experimental / Q000378:metabolism*; D010958:Plasminogen / Q000378:metabolism; D011480:Protease Inhibitors / Q000097:blood; D014361:Trypsin Inhibitors / Q000494:pharmacology
D002364:Caseins; D003470:Culture Media; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; D010958:Plasminogen